Category: Today’s Highlights
In a Market that Seems to Soar Today Our Eyes Are on These Biotech Firms
As the Market Seems to Soar Our Eyes Are on the Following Biotech Firms: Amgen ( AMGN ) : A rebounding is expected following an unwarranted decline. Gilead Sciences ( GILD ) : A lot of good news from the...
Read More
February 4, 2020
0
Could Nektar Product NKTR-214 Become a Blockbuster?
Nektar Therapeutics NKTR-214: A Blockbuster? Nektar Therapeutics ( NKTR ) published preclinical data of its immuno-oncology candidate NKTR-214 bempegaldesleukin (bempeg) succeeded in revealing the details of the drug’s actions that led to its successful outcome when used in monotherapy or in...
Read More
February 4, 2020
0
A Synopsis of Some Biotech Companies' Events
Synopsis The way many bloggers are interpreting the quarterly and yearly biotech companies’ financial results seems unfair and has proven to be. Amgen Amgen ( AMGN ) : The stock gained over $10 yesterday and is trading now at $231....
Read More
February 6, 2020
0
Why Regeneron Stock Is Soaring
Regeneron Pharmaceuticals Stock is Rallying Regeneron Pharmaceuticals ( REGN ) stock outperformed last week gaining over $27. The stock’s soaring was not the outcome of the market’s outperformance, for several consecutive days, but because the firm has announced great news...
Read More
February 10, 2020
0
A Letter to Subscribers
A Letter to Subscribers The complex brutal circumstances we are currently living in has made it imperative that we communicate with you so that you can understand how we at Prohost Biotech are acting in these difficult times. Current news...
Read More
June 30, 2020
0
Portola: On the right track
Portola Pharmaceuticals (PTLA) announced full results from ANNEXA-4, Phase 3b/4 trial of its Factor Xa inhibitor antidote Andexxa ® in patients experiencing acute major bleeding while taking a Factor Xa inhibitor. The data were presented at the International Stroke Conference 2019 and...
Read More
February 12, 2019
0
Cassava Sciences Has Good News from Alzheimer's Disease Trial. See Also: Theravance Biopharma
Cassava Sciences From NEWSWIRE we learned that Cassava Sciences ( SAVA ) , a clinical-stage biotechnology company focusing on Alzheimer’s disease, announced that The Journal of Prevention of Alzheimer’s Disease ( JPAD ), a peer-reviewed journal for the research community, has published...
Read More
February 12, 2020
0
Exelixis' excellent scientific and financial accomplishments
Exelixis’ (EXEL) financial results for the fourth quarter and full year 2018 are as inspiring as they are outstanding compared to many other small biotech firms that succeeded in putting products on the market. Revenues Exelixis total revenues ...
Read More
February 13, 2019
0
Nektar presentation today at the ASCO genitourinary cancers symposium
Today, at the 2019 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (GU) held at Moscone West in San Francisco, CA, Nektar (NKTR) will present preliminary efficacy, safety and immune monitoring data from the ongoing metastatic urothelial carcinoma (mUC)...
Read More
February 15, 2019
0
A Novel Immunotherapy Approach for the Treatment of COVID-19
Corvus Pharmaceuticals: FDA Granted IND Application for COVID-19 Trial The United States FDA granted approval of Corvus Pharmaceuticals ( CRVS ) investigational new drug ( IND ) application for a COVID-19 trial. Corvus announced the beginning of the Phase 1 study...
Read More
July 7, 2020
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)